Abstract | BACKGROUND: The sensitivity of mammography for the detection of small lesions, including node-negative early-stage (T1N0) primary breast cancer (PBC) and ductal carcinoma in situ ( DCIS), is significantly decreased in young patients. From a clinical standpoint, an inconclusive mammogram reflects the inability of clinicians to confidently decide whether patients should be referred for biopsy or for follow-up with repeat imaging. METHODS: Specific ELISAs were developed for a panel of 13 well-recognized breast autoantigens (HSP60, FKBP52, PRDX2, PPIA, MUC1, GAL3, PAK2, P53, CCNB1, PHB2, RACK1, RUVBL1, and HER2). Circulating autoantibody levels were measured in a cohort of 396 serum samples from histologically confirmed DCIS (n = 87) or T1N0 PBC (n = 153) and healthy controls (n = 156). RESULTS: Individually, antibodies against CCNB1, FKBP52, GAL3, PAK2, PRDX2, PPIA, P53, and MUC1 demonstrated discriminatory power between breast cancer and healthy control groups. At 90% sensitivity, the overall combined specificity of the autoantibody serum screening test was 42%. Adjustment for higher sensitivities of 95% and 99% resulted in 30% and 21% specificities, respectively (33% and 18% in T1N0 PBC and 28% and 21% in DCIS). Finally, in patients with node-negative early-stage breast cancer younger than 50 years, the autoantibody assay exhibited 59% specificity with a fixed sensitivity at 90%. CONCLUSIONS: IMPACT: Clinical assessment of this autoantibody panel displays a potential to facilitate clinical management of early-stage breast cancer detection in cases of inconclusive mammogram.
|
Authors | Jérôme Lacombe, Alain Mangé, Anne-Claire Bougnoux, Ioannis Prassas, Jérôme Solassol |
Journal | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
(Cancer Epidemiol Biomarkers Prev)
Vol. 23
Issue 9
Pg. 1834-42
(Sep 2014)
ISSN: 1538-7755 [Electronic] United States |
PMID | 24957886
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | ©2014 American Association for Cancer Research. |
Chemical References |
- Autoantibodies
- Biomarkers, Tumor
- PHB2 protein, human
- Prohibitins
|
Topics |
- Adult
- Aged
- Autoantibodies
(blood)
- Biomarkers, Tumor
(blood)
- Breast Neoplasms
(blood, diagnosis, diagnostic imaging, pathology)
- Carcinoma, Intraductal, Noninfiltrating
(blood, diagnosis, diagnostic imaging, pathology)
- Early Detection of Cancer
- Female
- Humans
- Lymphatic Metastasis
- Mammography
- Middle Aged
- Prohibitins
|